The deal, which has an enterprise value of £3bn, is the first one by Cinven’s seventh fund
US buyout firm KKR has agreed to sell the life sciences company LGC Group to a consortium jointly led by private equity groups Cinven and Astorg.
The deal has an enterprise value of approximately £3bn, a personal familiar with the transaction told Private Equity News. KKR has made about three times its money since the acquisition of the company from Bridgepoint in 2015, the person said.
The private equity firms declined to comment on the financial terms of the transaction.
The investment is the first deal struck by Cinven’s seventh fund, closed in May after raising €10bn to invest in European buyouts and selective North American opportunities.
LGC, which provides measurement and testing solutions, reported a revenue of £448m in 2019, with organic revenue growth accelerating to 10% per annum since 2016. Under KKR’s ownership, the company made 15 acquisitions in the last five years.
London-based Cinven and Paris-based Astorg said they identified LGC as an attractive investment opportunity because of its “strong performance and organic growth” and they saw “significant future development opportunities”.
Established in 1842, LGC employs more than 3,200 people, is headquartered in the UK and serves almost 50,000 laboratories worldwide from its global office network spanning 22 countries across five continents.
“Cinven’s investment in LGC was identified as a result of the healthcare sector team’s focus on the life sciences space,” said Supraj Rajagopalan, partner at Cinven. “LGC is exposed to a wide range of diversified and fast-growing end markets across the Standards and Genomics sectors and we look forward to working with the highly experienced management team to continue investing in strengthening and broadening LGC’s global footprint and portfolio of leading, high-quality products.”
The deal is still subject to regulatory approvals.
Source: Private Equity News
Can’t stop reading? Read more
Private equity’s AI reckoning has nothing to do with technology
Private equity’s AI reckoning has nothing to do with technology Private equity’s engagement with artificial intelligence has reached a paradoxical stage where the tools work; but it remains unclear whether firms are prepared to change how they operate once those tools...
KKR exits Goodpack in $1.4bn sale back to founding Lam family
KKR exits Goodpack in $1.4bn sale back to founding Lam family KKR has agreed to sell Goodpack back to the company’s founding Lam family in a deal valuing the reusable bulk container provider at about $1.4bn, according to a source close to the transaction cited by the...
Bain Capital-backed Bob’s Discount Furniture targets $2.5bn valuation in US IPO
Bain Capital-backed Bob’s Discount Furniture targets $2.5bn valuation in US IPO Bob’s Discount Furniture is seeking a valuation of up to $2.48bn as it prepares for a US initial public offering. The Manchester, Connecticut-based retailer plans to raise as much as...